GSK plc (GSK)

NYSE: GSK · Real-Time Price · USD
37.03
+0.40 (1.09%)
Apr 23, 2025, 4:00 PM EDT - Market closed
1.09%
Market Cap 74.22B
Revenue (ttm) 39.28B
Net Income (ttm) 3.22B
Shares Out 4.08B
EPS (ttm) 0.78
PE Ratio 23.02
Forward PE 8.22
Dividend $1.55 (4.19%)
Ex-Dividend Date Feb 21, 2025
Volume 4,454,350
Open 37.07
Previous Close 36.63
Day's Range 36.77 - 37.29
52-Week Range 31.72 - 45.93
Beta 0.30
Analysts Hold
Price Target 47.00 (+26.92%)
Earnings Date Apr 30, 2025

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, infectious, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, inflammation, and other specialty medicine product... [Read more]

Sector Healthcare
Founded 1715
Employees 68,629
Stock Exchange NYSE
Ticker Symbol GSK
Full Company Profile

Financial Performance

In 2024, GSK's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for GSK stock is "Hold." The 12-month stock price forecast is $47.0, which is an increase of 26.92% from the latest price.

Price Target
$47.0
(26.92% upside)
Analyst Consensus: Hold
Stock Forecasts

News

LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed

The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.

2 days ago - FXEmpire

UK approves combination therapies of GSK's blood cancer drug Blenrep

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities for the treatment of a type of blood cancer in adults who had received at ...

6 days ago - Reuters

Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer's Disease

--76-week trial is evaluating the safety and efficacy of a progranulin-elevating candidate in slowing disease progression-- --Enrollment completed ahead of schedule-- SOUTH SAN FRANCISCO, Calif., Apri...

Other symbols: ALEC
6 days ago - GlobeNewsWire

AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices

PHILADELPHIA--(BUSINESS WIRE)-- #Arexvy--AREXVY recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices.

7 days ago - Business Wire

GSK's 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices

PHILADELPHIA--(BUSINESS WIRE)-- #Adolescents--GSK's 5-in-1 meningococcal vaccine PENMENVY receives positive recommendation from US Advisory Committee on Immunization Practices.

7 days ago - Business Wire

GSK in breach for misleading prescribing information on Omjjara, industry body says

British pharmaceutical giant GSK has not met required ethical and regulatory standards in its marketing and prescription information for its Omjjara drug, an industry self-regulatory body said on Tues...

8 days ago - Reuters

Trump Says Pharmaceutical Tariffs Coming in Near Future

President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with reporter...

9 days ago - Bloomberg Markets and Finance

Trump says US pharma tariffs coming in not-too-distant future

U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported pharmaceuticals in the not-too-distant future.

9 days ago - Reuters

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told...

12 days ago - CNBC

Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback

European stocks soared on Thursday after U.S. President Donald Trump's jarring about-turn on most tariffs. Tensions between Washington and Beijing remain high, however, with Trump ratcheting up duties...

13 days ago - CNBC

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Evan Seigerman, BMO, joins 'Fast Money' to talk the impact of tariffs on pharma space.

14 days ago - CNBC Television

Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out

The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally. Despite pledges to increase U.S. manufacturin...

14 days ago - Seeking Alpha

Explainer: Prescription drugs become a target in Trump's trade war

U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm t...

14 days ago - Reuters

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

Trump doubled down on plans to soon impose "major" pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.

14 days ago - CNBC

Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs

Drugmakers have said they're still unclear about whether Trump will impose tariffs on finished products or on active pharmaceutical ingredients.

14 days ago - WSJ

Pharmaceutical stocks fall as Trump doubles down on tariffs threat

Pharmaceutical stocks fell after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S. "very shortly." Shares of Eli Lilly, AbbVie, Bristol Myers Squ...

14 days ago - CNBC

GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025

PHILADELPHIA--(BUSINESS WIRE)--GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025.

14 days ago - Business Wire

Global pharma shares plunge as Trump doubles down on tariff threat

Global drugmakers' stocks dropped across the board after U.S. President Donald Trump reiterated plans for a "major" tariff on pharmaceutical imports, threatening an interwoven global supply chain, and...

14 days ago - Reuters

Trump teases targeted tariffs on overseas drug manufacturers

With the next set of White House–imposed tariffs just hours away from taking effect — including the attention-hogging 104% rate to be levied on products from China as they're imported into the U.S. — ...

Other symbols: AZNIHENVSPJPSNYXPH
14 days ago - Market Watch

ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases

- ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases - Programs will leverage ABL Bio's Grabody-B platform technology to effectively deliver...

17 days ago - PRNewsWire

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In GSK To Contact Him Directly To Discuss Their Options NEW YORK, NY /...

19 days ago - Accesswire

GSK resolves patent lawsuit against Pfizer over RSV vaccines

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent rights in its c...

Other symbols: PFE
20 days ago - Reuters

New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops

Researchers investigated whether the shingles (herpes zoster) vaccine can help prevent dementia. Previous studies suggest that certain herpes viruses may contribute to dementia, and vaccines might hav...

20 days ago - Benzinga

Pharma stocks survive market rout on tariff exemption, but uncertainty continues

Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from reciprocal tariffs, but executives and analysts warned it was premature to c...

Other symbols: AZNNVO
20 days ago - Reuters

Bernstein's Courtney Breen: Merck, Novo Nordisk, others at high risk from tariffs

Courtney Breen, Bernstein senior analyst, joins CNBC's 'Money Movers' to discuss how to draw the line between tariff risks and company financials in pharmaceuticals, which companies are most at risk, ...

Other symbols: MRKNVOABBVSNY
22 days ago - CNBC Television